Knockdown of Slug by RNAi inhibits the proliferation and invasion of HCT116 colorectal cancer cells

Qian,Jiang; Liu,Hong; Chen,Wangsheng; Wen,Kunming; Lu,Weidong; Huang,Chun; Fu,Zhongxue

doi:10.3892/mmr.2013.1604

Knockdown of Slug by RNAi inhibits the proliferation and invasion of HCT116 colorectal cancer cells

Authors:
- Jiang Qian
- Hong Liu
- Wangsheng Chen
- Kunming Wen
- Weidong Lu
- Chun Huang
- Zhongxue Fu
View Affiliations

Affiliations: Department of General Surgery, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China, Department of General Surgery, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: July 29, 2013 https://doi.org/10.3892/mmr.2013.1604
Pages: 1055-1059

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer is one of the most common alimentary malignancies. Slug has been shown to be an ideal target for cancer gene therapy by numerous studies due to its strong anti‑apoptotic effect. The elevated expression of Slug is a frequent genetic abnormality observed in colorectal cancer. In the present study, a Slug short hairpin RNA (shRNA) expression vector that was able to efficiently inhibit the expression of Slug in HCT116 cells was prepared. Following transfection, the mRNA expression levels were detected by RT‑PCR analysis. Western blotting detected a similar inhibition of the Slug protein levels in the cells transfected with the pGCsi‑Slug plasmid. Downregulation of Slug resulted in a significant inhibition of cancer cell growth in vitro. Cell invasion and apoptosis were decreased concomitantly with the reduction in Slug protein expression. These results suggested that RNA interference (RNAi) was able to downregulate the Slug protein level in HCT116 cells and significantly inhibit tumor growth in vitro. These findings suggest that RNAi has therapeutic potential for the treatment of colorectal cancer, as well as other types of cancer, by targeting the overexpression of oncogenes, including Slug.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT and Griffiths S: Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol. 103:974–981. 2008. View Article : Google Scholar : PubMed/NCBI
3	Cohen SJ, Cohen RB and Meropol NJ: Targeting signal transduction pathways in colorectal cancer - more than skin deep. J Clin Oncol. 23:5374–5385. 2005. View Article : Google Scholar : PubMed/NCBI
4	Waters C: Colon cancer: an overview. Pharmaceut J. 276:323–326. 2006.
5	Labianca R, Beretta G, Gatta G, de Braud F and Wils J: Colon cancer. Crit Rev Oncol Hematol. 51:145–170. 2004. View Article : Google Scholar
6	Nieto MA: The snail superfamily of zinc-finger transcription factors. Nature Rev Mol Cell Biol. 3:155–166. 2002. View Article : Google Scholar : PubMed/NCBI
7	Nieto MA, Sargent MG, Wilkinson DG and Cooke J: Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science. 264:835–839. 1994. View Article : Google Scholar : PubMed/NCBI
8	Haupt S, Alsheich-Bartok O and Haupt Y: Clues from worms: a Slug at Puma promotes the survival of blood progenitors. Cell Death Differ. 13:913–915. 2006. View Article : Google Scholar : PubMed/NCBI
9	Martin TA, Goyal A, Watkins G and Jiang WG: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 12:488–496. 2005. View Article : Google Scholar : PubMed/NCBI
10	Zhang KJ, Wang DS, Zhang SY, Jiao XL, Li CW, Wang XS, Yu QC and Cui HN: The E-cadherin repressor slug and progression of human hilar cholangiocarcinoma. J Exp Clin Cancer Res. 29:882010. View Article : Google Scholar : PubMed/NCBI
11	Zhang KJ, Zhang BY, Zhang KP, Tang LM, Liu SS, Zhu DM and Zhang DL: Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma. World J Gastroenterol. 16:2554–2557. 2010. View Article : Google Scholar : PubMed/NCBI
12	Yu Q, Zhang K, Wang X, Liu X and Zhang Z: Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res. 29:1192010. View Article : Google Scholar : PubMed/NCBI
13	Shih YJ, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Lin SB, Liou GY, Lee ML, Chen JJ, Hong TM, Yang SC, Su JL, Lee YC and Yang PC: Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res. 11:8070–8078. 2005. View Article : Google Scholar : PubMed/NCBI
14	Zhang K, Zhang S, Jiao X, Wang H, Zhang D, Niu Z, Shen Y, Lv L and Zhou Y: Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo. Med Oncol. 28:1089–1100. 2011. View Article : Google Scholar : PubMed/NCBI
15	Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S and Aikou T: Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 11:1174–1180. 2005.PubMed/NCBI
16	Kanayama H: Matrix metalloproteinases and bladder cancer. J Med Invest. 48:31–43. 2001.PubMed/NCBI
17	Shioiri M, Shida T, Koda K, Oda K, et al: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 94:1816–1822. 2006. View Article : Google Scholar : PubMed/NCBI
18	Chung-Faye GA and Kerr DJ: Innovative treatment for colon cancer. BMJ. 321:1397–1399. 2000. View Article : Google Scholar : PubMed/NCBI
19	Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI